Merck spends $11.5B for Acceleron, possible blockbuster drug
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
German group Curevac said Monday it will broaden its mRNA COVID vaccine trials to include new virus variants as it aims to file for EU approval in the second quarter.
Mar 22, 2021
0
3
A French lab will start producing Moderna's COVID-19 vaccine in March, while another will begin making the vaccine from Pfizer and BioNTech in April, Industry Minister Agnes Pannier-Runacher said Wednesday.
Feb 3, 2021
0
3
(HealthDay)—Office-based visits for behavioral and psychiatric conditions decreased in association with the COVID-19 pandemic, although increases in telemedicine visits offset these decreases, according to a research letter ...
Nov 20, 2020
0
3
Almost all blood donors had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from previous infection or vaccination by the third quarter of 2022, with the prevalence of hybrid immunity lowest for adults ...
Jun 9, 2023
0
8
US biotech company Novavax said Monday it hopes to file for British approval of its COVID-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States.
Mar 2, 2021
0
3
The EU's internal markets commissioner Thierry Breton hinted Sunday that the bloc might decide not to order AstraZeneca's coronavirus jab again following delays in delivering the first batches of the vaccine.
Apr 18, 2021
0
3
The U.S. biosimilar drug market emerged in 2015 to provide safe, effective, and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Jun 6, 2023
0
1
AstraZeneca plans to accelerate production of its COVID vaccine in the second quarter to support EU needs, the British pharmaceutical giant said Wednesday, announcing a deal with Germany's IDT Biologika.
Feb 10, 2021
0
0
Pharmaceutical giant Bayer announced Thursday it had agreed to pay $1.6 billion to settle nearly all claims filed in the United States over controversial birth control implant Essure.
Aug 20, 2020
0
0